621 related articles for article (PubMed ID: 30165480)
1. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
4. Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1.
Yu B; Liu D; Zhang H; Xie D; Nie W; Shi K; Yang P
Biomed Pharmacother; 2018 Oct; 106():1390-1395. PubMed ID: 30119211
[TBL] [Abstract][Full Text] [Related]
5. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
6. Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats.
Xu M; Li LP; He X; Lu XZ; Bi XY; Li Q; Xue XR
FASEB J; 2024 May; 38(9):e23654. PubMed ID: 38717442
[TBL] [Abstract][Full Text] [Related]
7. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
Wu QQ; Xu M; Yuan Y; Li FF; Yang Z; Liu Y; Zhou MQ; Bian ZY; Deng W; Gao L; Li H; Tang QZ
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1143-54. PubMed ID: 25713304
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
10. Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis.
Ma H; Yu S; Liu X; Zhang Y; Fakadej T; Liu Z; Yin C; Shen W; Locasale JW; Taylor JM; Qian L; Liu J
Circulation; 2019 Apr; 139(14):1725-1740. PubMed ID: 30636447
[TBL] [Abstract][Full Text] [Related]
11. SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.
Xin T; Lu C
Aging (Albany NY); 2020 Jul; 12(16):16224-16237. PubMed ID: 32721927
[TBL] [Abstract][Full Text] [Related]
12. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
13. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
[TBL] [Abstract][Full Text] [Related]
14. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
[TBL] [Abstract][Full Text] [Related]
15. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
17. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
18. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
19. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
